跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXALIPLATIN CONC FOR SOLN FOR INFUSION 50MG/10ML (HOSPIRA) - PPB Drug Approval Details
Approvals
/
PPB
/
OXALIPLATIN CONC FOR SOLN FOR INFUSION 50MG/10ML (HOSPIRA)
Approved
STANDARD
OXALIPLATIN CONC FOR SOLN FOR INFUSION 50MG/10ML (HOSPIRA)
Pfizer Corporation Hong Kong Limited
🇰🇪 Pharmacy and Poisons Board
Approval Date
Jun 21, 2024
Approval ID
44b3103f793421e2
Company
Pfizer Corporation Hong Kong Limited
Type
Standard
Approval Details
Approval Id
44b3103f793421e2
Product Name
OXALIPLATIN CONC FOR SOLN FOR INFUSION 50MG/10ML (HOSPIRA)
Drug Hk Name
OXALIPLATIN CONC FOR SOLN FOR INFUSION 50MG/10ML (HOSPIRA)
Registration Code
HK-57506
Company Name
Pfizer Corporation Hong Kong Limited
Company Detail Path
/organization/pfizer-corporation-hong-kong-limited
Registration Category
Part 1, Schedule 1 & Schedule 3 Poison
Sale Requirement
Prescription only Medicines
Registration Date
2009-02-09
Company Address
21/F, KERRY CENTRE, 683, KING'S ROAD, QUARRY BAY, HONG KONG
Active Ingredients
Approved
Quick Info
Agency
PPB
Country
🇰🇪
Approval Date
Jun 21, 2024
Approval ID
44b3103f793421e2
Type
Standard
Back to PPB Approvals